正商實業(00185.HK)未償還票據本金975.2萬美元及利息 構成違約
正商實業(00185.HK)公布,周二(12日)完成今年到期12.5厘優先票據之交換要約,有效提呈交換並獲接納的2023票據已被註銷。目前,本金總額為975.2萬美元的2023票據仍未償還。
根據2023票據的條款,所有未償還本金額連同其應計及未付利息將於到期日昨日(13日)到期應付。截至目前,公司尚未支付餘下未償還本金975.2萬美元及其利息。未於到期時支付有關本金將構成2023票據項下的違約事件。就仍未償還的2023票據而言,公司將繼續與該等持有人溝通。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.